Prevalence of malnutrition in adult patients previously treated with allogeneic hematopoietic stem-cell transplantation

被引:40
作者
Brotelle, Thibault [1 ,2 ]
Lemal, Richard [1 ,2 ]
Cabrespine, Aurelie [1 ,2 ]
Combal, Cecile [3 ]
Hermet, Eric [1 ,2 ]
Ravinet, Aurelie [1 ,2 ]
Bay, Jacques-Olivier [1 ,2 ]
Bouteloup, Corinne [4 ,5 ]
机构
[1] CHU Clermont Ferrand, Clin Adulte & Therapie Cellulaire, Serv Hematol, F-63000 Clermont Ferrand, France
[2] Univ Clermont Auvergne, EA7283, CIC501, F-63000 Clermont Ferrand, France
[3] CHU Clermont Ferrand, Serv Nutr Clin, F-63000 Clermont Ferrand, France
[4] CHU Clermont Ferrand, Serv Med Digest & Hepatobiliaire, F-63000 Clermont Ferrand, France
[5] Univ Clermont Auvergne, INRA, UNH, CRNH Auvergne, F-63000 Clermont Ferrand, France
关键词
Hemato-oncology; Nutritional status; Body composition; Muscle mass; Muscle strength; BODY-MASS INDEX; BIOELECTRICAL-IMPEDANCE ANALYSIS; LONGITUDINAL FOLLOW-UP; NON-RELAPSE MORTALITY; NUTRITIONAL-STATUS; PHASE-ANGLE; MARROW-TRANSPLANTATION; HOSPITAL ADMISSION; SURGICAL PATIENTS; INCREASED LENGTH;
D O I
10.1016/j.clnu.2017.03.016
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Introduction: Malnutrition is common after allogeneic hematopoietic stem cell transplantation (allo-HSCT), and is a well-known prognostic factor for survival. The nutritional status of patients in a long term after allo-HSCT is less well documented. The main objective of this study was to evaluate the prevalence of malnutrition in adult patients who underwent allo-HSCT more than one year ago. Secondary objectives were to assess body composition, muscle strength, and factors associated with malnutrition. Patients & methods: All allo-HSCT patients admitted into the University Hospital of Clermont-Ferrand between 1st January 1985 and 31st December 2012 were screened. Clinical and biological nutritional assessments included anthropometric measurements, serum nutritional proteins, body composition assessed by bioelectrical impedance, and upper-limb muscle strength (MS) measured by dynamometry. Hematological and nutritional data during and after hospital stay for allo-HSCT were retrospectively collected. Results: Eighty four allo-HSCT patients (52% men; mean age 54.4 +/- 12.5 years) were enrolled. Average follow-up after allo-HSCT was 56.4 +/- 47.5 months. Prevalence of malnutrition at the end of follow-up was 20%. Compared to well-nourished patients (WN group), undernourished patients (UN group) at the end of follow-up were significantly more likely to be undernourished (50% vs. 21%, p = 0.04) at hospital admission, and to have a Nutritional Risk Index of <97.5 (47% vs. 20%, p = 0.004). Compared to a reference population, mid-arm muscle circumference and MS were significantly more likely to be decreased in the UN group than in the WN group (35.3% vs. 8.9%, p = 0.017; 24% vs. 3%, p = 0.005, respectively); fat-free mass index and appendicular skeletal muscle mass index were decreased in 30.5% and 36.6% of all patients, respectively, with no difference between UN and WN groups. Chronic graft-versus-host disease was more frequent, although not significantly in the UN group (76% vs. 52%, p = 0.071). In multivariate analyses, the presence of malnutrition at hospital admission for allo-HSCT trended towards an increased risk of longer-term malnutrition (OR = 3.60 [0.95; 13.67], p = 0.06). Conclusion: Malnutrition is a frequent consequence of allo-HSCT, and may occur several months or years after allo-HSCT, particularly if malnutrition existed before allo-HSCT. Our findings support the need for specialized nutritional care for both before and after allo-HSCT. Furthermore, assessment of muscle mass may be a pertinent parameter of malnutrition in this instance. (C) 2017 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
引用
收藏
页码:739 / 745
页数:7
相关论文
共 40 条
  • [1] Phase angle from BIA as a prognostic and nutritional status tool for children and adolescents undergoing hematopoietic stem cell transplantation
    Alves Farias, Carolina Lane
    Campos, Denise Johnsson
    Sales Bonfin, Carmem Maria
    Vilela, Regina Maria
    [J]. CLINICAL NUTRITION, 2013, 32 (03) : 420 - 425
  • [2] [Anonymous], 2007, STRAT PRIS CHARG CAS
  • [3] Impact of sarcopenia on the prognosis and treatment toxicities in patients diagnosed with cancer
    Antoun, Sami
    Borget, Isabelle
    Lanoy, Emilie
    [J]. CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2013, 7 (04) : 383 - 389
  • [4] Malnutrition in patients with chronic GVHD
    Bassim, C. W.
    Fassil, H.
    Dobbin, M.
    Steinberg, S. M.
    Baird, K.
    Cole, K.
    Joe, G.
    Comis, L. E.
    Mitchell, S. A.
    Grkovic, L.
    Edwards, D.
    Mays, J. W.
    Cowen, E. W.
    Pulanic, D.
    Williams, K. M.
    Gress, R. E.
    Pavletic, S. Z.
    [J]. BONE MARROW TRANSPLANTATION, 2014, 49 (10) : 1300 - 1306
  • [5] ESPEN Guidelines on Parenteral Nutrition: Non-surgical oncology
    Bozzetti, F.
    Arends, J.
    Lundholm, K.
    Micklewright, A.
    Zurcher, G.
    Muscaritoli, M.
    [J]. CLINICAL NUTRITION, 2009, 28 (04) : 445 - 454
  • [6] STUDY PROTOCOL - A RANDOMIZED CLINICAL-TRIAL OF TOTAL PARENTERAL-NUTRITION IN MALNOURISHED SURGICAL PATIENTS
    BUZBY, GP
    KNOX, LS
    CROSBY, LO
    EISENBERG, JM
    HAAKENSON, CM
    MCNEAL, GE
    PAGE, CP
    PETERSON, OL
    REINHARDT, GF
    WILLIFORD, WO
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 1988, 47 (02) : 366 - 381
  • [7] DEEG HJ, 1995, BONE MARROW TRANSPL, V15, P461
  • [8] Utility of standard nutritional parameters in detecting body cell mass depletion in patients with end-stage liver disease
    Figueiredo, FA
    Dickson, ER
    Pasha, TM
    Porayko, MK
    Therneau, TM
    Malinchoc, M
    DiCecco, SR
    Francisco-Ziller, NM
    Kasparova, P
    Charlton, MR
    [J]. LIVER TRANSPLANTATION, 2000, 6 (05) : 575 - 581
  • [9] NEW NORMS OF UPPER LIMB FAT AND MUSCLE AREAS FOR ASSESSMENT OF NUTRITIONAL-STATUS
    FRISANCHO, AR
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 1981, 34 (11) : 2540 - 2545
  • [10] Severe weight loss in 3 months after allogeneic hematopoietic SCT was associated with an increased risk of subsequent non-relapse mortality
    Fuji, S.
    Mori, T.
    Khattry, N.
    Cheng, J.
    Do, Y. R.
    Yakushijin, K.
    Kohashi, S.
    Fukuda, T.
    Kim, S-W
    [J]. BONE MARROW TRANSPLANTATION, 2015, 50 (01) : 100 - 105